Skip to content

Illumina ILMN Operating Cash Flow

Operating Cash Flow at other companies

Revvity logo
RevvityRVTY
$115.23M-10.1%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$1.19B+64.9%
Azenta logo
AzentaAZTA
$13.51M-6.2%
Pacific Biosciences of California logo
Pacific Biosciences of CaliforniaPACB
-$44.69M-1.4%
Personalis, Inc. logo
Personalis, Inc.PSNL
-$22.48M-25.1%
Guardant Health logo
Guardant HealthGH
-$65.62M-4.7%

Other financials

Income statement

See full
Revenue$1.1B+4.8%
Gross profit$721.0M+5.6%
Operating income$209.0M+27.4%
Net income$134.0M+2.3%
EPS (diluted)$0.87+6.1%

Balance sheet

See full
Cash & equivalents$1.1B-2.2%
Total debt$2.0B-3.0%
Total equity$2.7B+13.0%
Total assets$6.6B+6.1%

Cash flow

See full
CapEx$38.0M+18.8%
Free cash flow$251.0M+20.7%

Valuation

See full
Market cap$26.6B+91.5%
Enterprise value$27.56B+83.6%
P/E31.2×+20.1×
P/S6.1×+2.8×

Profitability

See full
Gross margin66.2%-0.1pp
Operating margin19.4%
Net margin19.4%+12.7pp
FCF margin22.2%+2.0pp

Returns & leverage

See full
Return on equity33.8%+23.9pp
Debt / equity0.8×-0.1×
Current ratio1.7×-0.1×

Where this comes from

Reported directly by Illumina in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: Illumina’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Illumina's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Illumina's operating cash flow?
Illumina (ILMN) reported operating cash flow of $289M in Q1 2026.
How has Illumina's operating cash flow changed year-over-year?
Illumina's operating cash flow increased by 20.4% year-over-year, from $240M to $289M.
What is the long-term trend for Illumina's operating cash flow?
Over 2 years (2023 to 2025), Illumina's operating cash flow has grown at a 50.2% compound annual growth rate (CAGR), from $478M to $1.08B.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.